Is g2/M cell cycle checkpoint functional in cervical cancer patients after initiation of external beam radiotherapy?
RT leads to significant changes in the cell cycle in cervical cancer indicating intact G2/M checkpoint function. Targeting G2/M with compounds interfering with G2/M transition may further enhance the effect of RT in cervical cancer patients.
Lower provider volume is associated with higher failure rate for ERCP, and greater need for postprocedure hospitalization.